Latest Publications
Improved Pharma Adds UHPLC Capabilities to Service Offerings
WEST LAFAYETTE, Ind., July 15, 2024 /PRNewswire-PRWeb/ -- Improved Pharma is pleased to announce it has recently purchased an Agilent 1290 Infinity II LC System. This instrument is housed in their chromatography laboratory andRead more
Using Optical Microscopy, Hot Stage Microscopy, and DSC Microscopy for Co-Processing Strategies – By Steve Byrn and Dale Purcell
This blog focuses on how microscopy, hot-stage microscopy, and DSC microscopy can be used to develop co-processing strategies and relies heavily on input from Chemical Microscopy LLC, which is closely linked to Improved Pharma.Read more
Improved Pharma announces addition of John Torchia to the team
WEST LAFAYETTE, Ind., July 11, 2024 /PRNewswire-PRWeb/ -- Improved Pharma is pleased to announce a new collaboration with John Torchia of Asterane Pharma LLC. John brings 20 years of experience in the pharmaceutical industry, specializing in UPLC /Read more
Improved Pharma continues growth adding microscopy laboratory in 2024
WEST LAFAYETTE, Ind., June 18, 2024 /PRNewswire-PRWeb/ -- Improved Pharma is pleased to announce it has expanded by adding a dedicated microscopy laboratory adjacent to its existing laboratory space in the Kurz Technology Center atRead more
Analytical Methods for Studying Co-processed Pharmaceutical Solids – By Steve Byrn
Our first blog post on co-processed pharmaceutical solids provided a general introduction. A second blog discussed an approach to screening for co-processed pharmaceutical solids. This third blog focuses on analytical methods for studying co-processedRead more
Mission success: Ritonavir crystallization experiments conducted in space worked flawlessly
WEST LAFAYETTE, Ind., March 22, 2024 /PRNewswire-PRWeb/ -- Improved Pharma and Varda Space Industries have published the first mission results in ChemRxiv in an article entitled Return of the Ritonavir: A Study on the Stability ofRead more